Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma (NCT05609695) | Sun Yat-sen University | 2023-03-01 |
Track Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.